Unresectable Uveal Melanoma
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB15283 | Tebentafusp | A bispecific gp100 peptide-HLA-directed CD3 T cell engager used to treat unresectable or metastatic uveal melanoma. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB15283 | Tebentafusp | Melanocyte protein PMEL | target |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB08911 | Trametinib | 1 / 2 | Withdrawn | 1 |